Happy #WorldScienceDay! At Mnemo our science helps the human body identify, fight and overcome disease. Learn more about the power of our EnfiniT platform here: mnemo-tx.com/our-technology/

I just subscribed to Ground Truths, highly recommended. erictopol.substack.com/?utm_medium=we…

Mnemo is #hiring! We’re looking for a Senior Director of Viral Vector and Gene Delivery Process Development in our New Jersey lab (hybrid). Passionate about building and optimizing workflows to fuel high-performing teams? Apply here: bit.ly/35QIFFp #biotech #careers

We’re #hiring a Senior Director of Gene Editing Technology in our New Jersey lab (hybrid) to join us in advancing our EnfiniT platform, a next-generation toolkit for CAR T immunotherapy aiming to bring curative therapies to patients. Learn more: linkedin.com/jobs/view/2877… #careers

Today Mnemo Therapeutics announced the appointment of Robert LaCaze as CEO, effective May 1. Robert brings a distinguished track record overseeing clinical development, strategy & operations and commercialization for leading global biopharma companies. bit.ly/3JNlsCz

Spread the word: mathew.maurer Ronald Witteles Mazen Hanna Frederick L Ruberg Brett Sperry, MD Vincent Rajkumar Michelle Kittleson MD PhD David Fermin, MD Omar AbouEzzeddine MDCM, MS (He/Him/His) Melissa Lyle Julie Lorraine Rosenthal Mayo Amyloid Vaishali Sanchorawala Ahmad Masri Michael Chetrit Dr. Jeffrey Zonder

Nice progress for in vivo gene editing field 1.0 mg/kg 6 patients TTR down mean of 93% Durable for the months followed so far Consistent across patients No liver AEs, no major AEs 👏👏👏 Intellia Therapeutics globenewswire.com/news-release/2…

We’re looking for a Senior Director of Analytical R&D to join the Mnemo team in our Paris lab (hybrid). We are working to transform the body’s immune response to overcome currently incurable diseases through our EnfiniT platform – are you ready? Join us: linkedin.com/jobs/view/2882…

Don’t miss Mnemo CEO Alain Maiore at the Oppenheimer & Co. Inc. 32nd Annual Healthcare Conference, presenting today at 11:20am ET! #OPCOHC2022

#AI enhanced ECG to detect cardiac #amyloidosis also predicts survival, independent of biomarker stage. @drpaulfriedman @preventingCVD Melissa Lyle Julie Lorraine Rosenthal Mayo Clinic Rochester Cardiology Fellows Mayo Amyloid Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Ahmad Masri Mazen Hanna mathew.maurer #ACC22 #ACC2022

How do CAR-T cells kill tumor cells? - It depends… Exciting work nature by Dr Marcela Maus Rebecca Larson & colleagues on the role of IFNg signaling in CAR-T mediated killing. Congrats to the entire team! nature.com/articles/s4158…

Early morning flight. KN95 for sure. Only ~30% masked here at PHL. Expect another viral blip in about 2 weeks. But don’t worry- no one will get sick. No one will get long COVID. Your employees will not call out sick for weeks…

Mnemo is #hiring! We’re looking for a CBO to lead business development and help us further develop Mnemo as a global biotech. Join us in our quest to create the most powerful immune therapies to deliver accessible cures for all patients in need. #biotech bit.ly/3vNrpdF

I believe it - there are advantages to in person interactions.👫🏾 Virtual communication curbs creative idea generation | Nature nature.com/articles/s4158…

A robust combination of scientific knowledge and strategic prowess will be critical for Mnemo to realize its ambitions as a fully integrated, global #biotech. We are excited to officially welcome #biopharma industry veteran Robert LaCaze to the team as #CEO to lead these efforts!

Our COO, Alain Meier Maiore, is excited to represent Mnemo at BioCentury’s #BioEquity Europe conference in Milan this week! It’s an honor to meet other #biopharma executives and rising #biotech companies to talk the future of #health sciences. Register here! bit.ly/3wc0f1n

Welcome to parity, U.S. Soccer U.S. Soccer Men's National Team U.S. Women's National Soccer Team We've had it for nearly a decade now in professional squash, and our game has been utterly transformed @PSAWorldTour U.S. Open Squash nytimes.com/2022/05/18/spo…

Mnemo is excited to announce a publication in Cell Reports from the lab of our scientific Co-Founder Sebastian Amigorena, PhD. This paper provides foundational proof-of-concept for a unique approach to discovering novel cancer-specific antigens Learn more: bit.ly/3xKJ7Rf

I’m at the point where I will rather quit than do American Board of Internal Medicine (ABIM) Longitudinal Knowledge Assessment (LKA) and try to keep ABIM certification active. It’s interfering with patient care and research for me. And I’m getting the myeloma questions wrong. Useless. Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 #MedTwitter

Wow. #immunotherapy #myeloma